Joanne C. Mountford

4.5k total citations
69 papers, 3.2k citations indexed

About

Joanne C. Mountford is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Joanne C. Mountford has authored 69 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 19 papers in Hematology and 18 papers in Genetics. Recurrent topics in Joanne C. Mountford's work include Pluripotent Stem Cells Research (20 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Joanne C. Mountford is often cited by papers focused on Pluripotent Stem Cells Research (20 papers), Chronic Myeloid Leukemia Treatments (15 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Joanne C. Mountford collaborates with scholars based in United Kingdom, United States and Netherlands. Joanne C. Mountford's co-authors include Tessa L. Holyoake, Niove E. Jordanides, Heather G. Jørgensen, Elaine Allan, Lucy J. Elrick, Mhairi Copland, Ashley Hamilton, Janet W. Baird, Andrew H. Baker and Christopher M. Bunce and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and Blood.

In The Last Decade

Joanne C. Mountford

68 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanne C. Mountford United Kingdom	31	1.6k	1.2k	982	532	482	69	3.2k
Mingjiang Xu United States	34	3.0k 1.9×	1.7k 1.3×	1.5k 1.5×	499 0.9×	585 1.2×	101	4.4k
Frédéric Larbret France	20	1.1k 0.7×	746 0.6×	569 0.6×	332 0.6×	197 0.4×	32	2.0k
David J. Shields United States	23	1.7k 1.1×	520 0.4×	275 0.3×	634 1.2×	145 0.3×	44	3.2k
Max Chaffanet France	36	2.4k 1.5×	953 0.8×	756 0.8×	1.0k 1.9×	295 0.6×	105	4.4k
Kimberly Straley United States	16	1.3k 0.8×	358 0.3×	470 0.5×	743 1.4×	174 0.4×	25	3.1k
Fabı́ola Traina Brazil	28	1.2k 0.7×	1.3k 1.0×	909 0.9×	239 0.4×	149 0.3×	160	2.6k
Cristina E. Tognon United States	26	2.0k 1.2×	691 0.6×	458 0.5×	705 1.3×	153 0.3×	81	3.6k
Judith Staerk Belgium	22	3.1k 1.9×	2.0k 1.6×	2.9k 3.0×	148 0.3×	1.1k 2.3×	34	5.0k
Robert Ilaria United States	26	1.0k 0.6×	1.3k 1.0×	833 0.8×	195 0.4×	427 0.9×	57	3.1k

Countries citing papers authored by Joanne C. Mountford

Since Specialization

Citations

This map shows the geographic impact of Joanne C. Mountford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne C. Mountford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne C. Mountford more than expected).

Fields of papers citing papers by Joanne C. Mountford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne C. Mountford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne C. Mountford. The network helps show where Joanne C. Mountford may publish in the future.

Co-authorship network of co-authors of Joanne C. Mountford

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne C. Mountford. A scholar is included among the top collaborators of Joanne C. Mountford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne C. Mountford. Joanne C. Mountford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ross, Ewan A., Lesley-Anne Turner, Hannah Donnelly, et al.. (2023). Nanotopography reveals metabolites that maintain the immunomodulatory phenotype of mesenchymal stromal cells. Nature Communications. 14(1). 753–753. 24 indexed citations

McCracken, Ian R, Ross Dobie, Abdelaziz Beqqali, et al.. (2022). Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression. Cardiovascular Research. 118(14). 2960–2972. 35 indexed citations

Spiroski, Ana‐Mishel, Ian R McCracken, Adrian Thomson, et al.. (2022). Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction. Frontiers in Cardiovascular Medicine. 9. 953211–953211. 4 indexed citations

Ham, Renske M.T. ten, Jarno Hoekman, Rachel Cooper, et al.. (2021). Estimation of manufacturing development costs of cell-based therapies: a feasibility study. Cytotherapy. 23(8). 730–739. 17 indexed citations

Forbes, Shareen, Andrew Bond, Paul S. Burgoyne, et al.. (2020). Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization. Science Translational Medicine. 12(526). 42 indexed citations

Zabaleta, Nerea, Raúl Torres, Rebeca Sánchez‐Domínguez, et al.. (2020). In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Precise Deletions Using CRISPR-Cas9. Molecular Therapy — Methods & Clinical Development. 19. 426–437. 9 indexed citations

Mountford, Joanne C., Kay Samuel, Laura Bailey, et al.. (2020). Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions. Cytotherapy. 22(12). 762–771. 9 indexed citations

Lopez‐Yrigoyen, Martha, Chengtao Yang, A Fidanza, et al.. (2019). Genetic programming of macrophages generates an in vitro model for the human erythroid island niche. Nature Communications. 10(1). 881–881. 46 indexed citations

MacAskill, Mark G., Jaimy Saif, Alison Condie, et al.. (2018). Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product. Molecular Therapy. 26(7). 1669–1684. 52 indexed citations

10.

MacAskill, Mark G., Adriana Tavares, Junxi Wu, et al.. (2017). PET Cell Tracking Using 18F-FLT is Not Limited by Local Reuptake of Free Radiotracer. Scientific Reports. 7(1). 44233–44233. 12 indexed citations

11.

McGowan, Neil, John Campbell, & Joanne C. Mountford. (2017). Good Manufacturing Practice (GMP) Translation of Advanced Cellular Therapeutics: Lessons for the Manufacture of Erythrocytes as Medicinal Products. Methods in molecular biology. 1698. 285–292. 8 indexed citations

12.

Kennedy, L., et al.. (2012). Derivation of Vascular Endothelial Cells from Human Embryonic Stem Cells Under GMP-Compliant Conditions: Towards Clinical Studies in Ischaemic Disease. Journal of Cardiovascular Translational Research. 5(5). 605–617. 18 indexed citations

13.

Yung, Sun, Inmaculada Moreno, Ana Conesa, et al.. (2011). Large-scale transcriptional profiling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells. Human Molecular Genetics. 20(24). 4932–4946. 15 indexed citations

14.

Hatziieremia, Sophia, Niove E. Jordanides, Tessa L. Holyoake, Joanne C. Mountford, & Heather G. Jørgensen. (2009). Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34+ cells to imatinib. Experimental Hematology. 37(6). 692–700. 24 indexed citations

15.

Davies, Andrea, Niove E. Jordanides, Athina Giannoudis, et al.. (2009). Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters. Leukemia. 23(11). 1999–2006. 84 indexed citations

16.

Strathdee, Gordon, Tessa L. Holyoake, Anton Parker, et al.. (2007). Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis. Clinical Cancer Research. 13(17). 5048–5055. 103 indexed citations

17.

Jørgensen, Heather G., Elaine Allan, Linda Richmond, et al.. (2005). Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro. Leukemia. 19(7). 1184–1191. 57 indexed citations

18.

Mountford, Joanne C., et al.. (2004). Functional ABCG2 Is Expressed on CML Stem Cells and Its Inhibition Selectively Depletes CML CD34+ Cells.. Blood. 104(11). 716–716. 1 indexed citations

19.

Mountford, Joanne C., et al.. (2001). 1α,25-dihydroxyvitamin D3 displays divergent growth effects in both normal and malignant cells. Steroids. 66(3-5). 433–440. 20 indexed citations

20.

Bunce, Christopher M., Joanne C. Mountford, Philip J. French, et al.. (1996). Potentiation of myeloid differentiation by anti-inflammatory agents, by steroids and by retinoic acid involves a single intracellular target, probably an enzyme of the aldoketoreductase family. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1311(3). 189–198. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact